Liver
Resources for understanding and treating issues that affect the liver in HHT patients including liver AVMs, liver failure, and liver transplantation.
Related Resources
Bevacizumab for treating HHT patients with severe hepatic involvement or refractory anemia
Scientific Literature – 2020PLoS One. Authors: Carolina Vázquez, María Laura Gonzalez, Augusto Ferraris, Juan Carlos Bandi, and Marcelo Martín Serra. This article is available for public use and does not require purchase. Click to view the full article.
MoreThe Science Behind the 2019 Scientific Conference (recorded)
Webinar – 2020Philippe Marambaud, PhD and Andy White, MD discuss important advances in HHT research which were presented at the 2019 HHT International Scientific Conference in Puerto Rico. Learn about advancements in drug therapies for bleeding, screening and trea…
MoreHHT Scientific Conference Summaries (recorded)
Webinar – 2018Drs. Hughes, Faughnan and Andrejecsk provide a first hand synopsis of the HHT science presented in Dubrovnik, Croatia where over 200 voices were heard from 23 countries. They reviewed the 12th HHT International Conference Executive Summary of…
MoreExecutive Summary – 12th HHT International Scientific Conference (2017)
Scientific Literature – 2017Angiogenesis. Authors: Jillian W. Andrejecsk, Anna E. Hosman, Luisa M. Botella, Claire L. Shovlin, Helen M. Arthur, Sophie Dupuis-Girod, Elisabetta Buscarini, Christopher C. W. Hughes, Franck Lebrin, Christine L. Mummery, Marco C. Post, and Johannes…
MoreHereditary Haemorrhagic Telangiectasia: Novel cardiopulmonary insights
Scientific Literature – 2017Author: Veronique M.M. Vorselaars. This article is available for public use and does not require purchase. Click to view the full article.
MoreExecutive Summary – 11th HHT International Scientific Conference (2015)
Scientific Literature – 2015Angiogenesis. Authors: Helen Arthur, Urban Geisthoff, James R. Gossage, Christopher C. W. Hughes, Pascal Lacombe, Mary E. Meek, Paul Oh, Beth L Roman, Scott O. Trerotola, Sebastiaan Velthuis, and Whitney Wooderchak-Donahue. This article can be purcha…
MoreCardiac and Liver Manifestations (recorded)
Webinar – 2015Dr. Kevin Whitehead, Co-Director at the University of Utah HHT Center of Excellence, covers various ways that the heart can be affected in HHT, including heart failure due to liver AVMs and pulmonary hypertension. The presentation is followed by a Q…
MoreBevacizumab: Finding its Niche in the Treatment of Heart Failure Secondary to Liver Vascular Malformations in HHT
Scientific Literature – 2013Hepatology. Authors: Lawrence H. Young, Katharine J. Henderson, Robert I. White, and Guadalupe Garcia-Tsao. This article is available for public use and does not require purchase. Click to view the full article.
MoreHepatobiliary and Pancreatic: Pancreatic Vascular Malformations in HHT
Scientific Literature – 2012Journal of Gastroenterology and Hepatol. Authors: K. Lim, W. Tam, C. Worthley, and N. Q. Nguyen. This article is available for public use and does not require purchase. Click to view the full article.
MoreBevacizumab Reverses Need for Liver Transplantation in HHT
Scientific Literature – 2008Liver Transplantation. Authors: Andrew Mitchell, Leon A. Adams, Gerry MacQuillan, Jon Tibballs, Rohan vanden Driesen, and Luc Delriviere. This article is available for public use and does not require purchase. Click to view the full article.
MoreLiver Transplantation for Cardiac Failure in Patients with HHT
Scientific Literature – 2005Liver Transplantation. Authors: Thierry Thevenot, Claire Vanlemmens, Vincent Di Martino, Marie-Claude Becker, Pierre-Olivier Denue, Bernadette Kantelip, Solange Bresson-Hadni, Bruno Heyd, Georges Mantion, and Jean-Philippe Miguet. This article is ava…
MoreRelated News
Online Education: Sclerotherapy
Join us to learn about sclerotherapy, an innovative treatment offering hope to HHT patients suffering from chronic nosebleeds. Dr. Jay Piccirillo, ENT at Washington University, will explain how this m…